These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 11587226)
1. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Dugray A; Geay JF; Foudi A; Bonnet ML; Vainchenker W; Wendling F; Louache F; Turhan AG Leukemia; 2001 Oct; 15(10):1658-62. PubMed ID: 11587226 [TBL] [Abstract][Full Text] [Related]
2. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572 [TBL] [Abstract][Full Text] [Related]
3. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Zhang X; Ren R Blood; 1998 Nov; 92(10):3829-40. PubMed ID: 9808576 [TBL] [Abstract][Full Text] [Related]
4. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Zhao RC; McIvor RS; Griffin JD; Verfaillie CM Blood; 1997 Dec; 90(12):4687-98. PubMed ID: 9389683 [TBL] [Abstract][Full Text] [Related]
6. Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression. Klucher KM; Lopez DV; Daley GQ Blood; 1998 May; 91(10):3927-34. PubMed ID: 9573031 [TBL] [Abstract][Full Text] [Related]
7. [Stable interference on P210(bcr/abl) gene expression by lentiviral vector-delivered shRNA in vitro and in vivo]. Zhu YF; Wang YZ; Meng FY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1090-4. PubMed ID: 23114125 [TBL] [Abstract][Full Text] [Related]
8. A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector. Zhao RC; Jiang Y; Verfaillie CM Blood; 2001 Apr; 97(8):2406-12. PubMed ID: 11290604 [TBL] [Abstract][Full Text] [Related]
9. Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines. Martiat P; Lewalle P; Taj AS; Philippe M; Larondelle Y; Vaerman JL; Wildmann C; Goldman JM; Michaux JL Blood; 1993 Jan; 81(2):502-9. PubMed ID: 8422466 [TBL] [Abstract][Full Text] [Related]
10. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838 [TBL] [Abstract][Full Text] [Related]
11. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system]. Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320 [TBL] [Abstract][Full Text] [Related]
12. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis. Lidonnici MR; Corradini F; Waldron T; Bender TP; Calabretta B Blood; 2008 May; 111(9):4771-9. PubMed ID: 18227349 [TBL] [Abstract][Full Text] [Related]
13. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization. Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246 [TBL] [Abstract][Full Text] [Related]
14. Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7. Issaad C; Ahmed M; Novault S; Bonnet ML; Bennardo T; Varet B; Vainchenker W; Turhan AG Leukemia; 2000 Apr; 14(4):662-70. PubMed ID: 10764152 [TBL] [Abstract][Full Text] [Related]
15. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442 [TBL] [Abstract][Full Text] [Related]
16. BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Chalandon Y; Jiang X; Christ O; Loutet S; Thanopoulou E; Eaves A; Eaves C Leukemia; 2005 Mar; 19(3):442-8. PubMed ID: 15674417 [TBL] [Abstract][Full Text] [Related]
17. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate. Era T; Witte ON Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1737-42. PubMed ID: 10677527 [TBL] [Abstract][Full Text] [Related]
18. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Hofmann A; Nolan GP; Blau HM Proc Natl Acad Sci U S A; 1996 May; 93(11):5185-90. PubMed ID: 8643550 [TBL] [Abstract][Full Text] [Related]
19. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Gross AW; Ren R Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343 [TBL] [Abstract][Full Text] [Related]
20. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Gesbert F; Griffin JD Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]